Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus

Autoimmun Rev. 2023 Jan;22(1):103213. doi: 10.1016/j.autrev.2022.103213. Epub 2022 Oct 14.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple organs involvement, abundant autoantibodies, complement activation, and immune complexes depositions. By regulating inflammation and immune homeostasis, cytokines have been well documented to participate in the pathogenesis of SLE. A number of studies have shown that T helper 2 (Th2)-associated immunity plays an important role in autoimmune diseases, including SLE. Key molecules underlying Th2-related immunity are expected to serve as promising targets for the diagnosis and targeted treatment of SLE. Current progress in SLE pathogenesis and biological treatment strategies has been reviewed, focusing on the latest development in Th2-associated immunity.

Keywords: Cytokines; Immune homeostasis; Polarization; Systemic lupus erythematosus; Th2-associated immunity.

Publication types

  • Review

MeSH terms

  • Autoantibodies
  • Autoimmune Diseases*
  • Cytokines
  • Humans
  • Inflammation
  • Lupus Erythematosus, Systemic*

Substances

  • Autoantibodies
  • Cytokines